Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipoatrophic Diabetes Mellitus”

47 trials

Showing 20 of 47 results

Large-scale testing (Phase 3)Study completedNCT00770952
What this trial is testing

Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus
Takeda 91
Post-approval studies (Phase 4)Study completedNCT00494312
What this trial is testing

Safety Study of Pioglitazone Compared To Glyburide on Liver Function

Who this might be right for
Diabetes MellitusLiver
Takeda 2,120
Large-scale testing (Phase 3)Active Not RecruitingNCT06548100
What this trial is testing

The Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)

Who this might be right for
Generalized Lipodystrophy
Regeneron Pharmaceuticals 9
Large-scale testing (Phase 3)Study completedNCT00331487
What this trial is testing

Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia

Who this might be right for
Diabetes Mellitus
Takeda 719
Large-scale testing (Phase 3)Study completedNCT00772174
What this trial is testing

Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus
Takeda 418
Large-scale testing (Phase 3)Study completedNCT00395512
What this trial is testing

Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 655
Post-approval studies (Phase 4)Study completedNCT00672919
What this trial is testing

Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.

Who this might be right for
Diabetes Mellitus
Takeda 305
Testing effectiveness (Phase 2)Study completedNCT03514420
What this trial is testing

Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL)

Who this might be right for
Familial Partial Lipodystrophy
Akcea Therapeutics 4
Large-scale testing (Phase 3)Study completedNCT00727857
What this trial is testing

Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus
Takeda 600
Post-approval studies (Phase 4)Study completedNCT00770445
What this trial is testing

Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus
Takeda 121
Large-scale testing (Phase 3)Study completedNCT00286442
What this trial is testing

Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 527
Testing effectiveness (Phase 2)Study completedNCT00760344
What this trial is testing

Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 386
Large-scale testing (Phase 3)Study completedNCT00521742
What this trial is testing

Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease

Who this might be right for
Diabetes Mellitus
Takeda 300
Large-scale testing (Phase 3)Study completedNCT00174993
What this trial is testing

Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus
Takeda 4,373
Testing effectiveness (Phase 2)Study completedNCT00762736
What this trial is testing

Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 704
Large-scale testing (Phase 3)Study completedNCT00286429
What this trial is testing

Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus
Takeda 390
Large-scale testing (Phase 3)Study completedNCT00306384
What this trial is testing

Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 3,323
Large-scale testing (Phase 3)Study completedNCT00432276
What this trial is testing

Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 803
Testing effectiveness (Phase 2)Study completedNCT00676260
What this trial is testing

Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With Insulin

Who this might be right for
Diabetes Mellitus
Takeda 29
Post-approval studies (Phase 4)Study completedNCT00754403
What this trial is testing

Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus
Takeda 312
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation